Collaborating with Paramount Bed to contribute to medical safety measures at Tokyo Nishitokushukai Hospital

Home » corporate » News » 2023 » Collaborating with Paramount Bed to contribute to medical safety measures at Tokyo Nishitokushukai Hospital
2023.08.31 Press release

--To the press -

Collaborating with Paramount Bed to contribute to medical safety measures at Tokyo Nishitokushukai Hospital

Collaboration of fall prediction AI system "Coroban" and "smart bed system", enabling one-stop patient information confirmation

FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)

 FRONTEO Co., Ltd. (Headquarters: Minato-ku, Tokyo, President and CEO: Masahiro Morimoto, hereinafter FRONTEO) is collaborating with Paramount Bed Co., Ltd. (Headquarters: Koto-ku, Tokyo, President and CEO: Tomohiko Kimura, hereinafter Paramount Bed). By linking the systems of the two companies, we will contribute to the medical safety measures of Tokushukai Medical Corporation Tokyo Nishi-Tokushukai Hospital (location: Akishima City, Tokyo; Director: Kazuhiko Sato; hereinafter referred to as Tokyo Nishi-Tokushukai Hospital). We would like to inform you that

 Tokyo Nishi-Tokushukai Hospital is the regional core hospital with 32 clinical departments and 524 beds.The hospital uses FRONTEO's fall prediction AI system in two wards."Coroban"and Paramount Bed"Smart bed system"is being introduced.

 Recently, Tokyo Nishi-Tokushukai Hospital requested that Coroban alerts be displayed on the terminal of the smart bed system, so the two companies collaborated on additional development.We believe that this will enable one-stop information confirmation and assessment, contributing to the smooth provision of care and the promotion of medical safety measures.


Example of display on bedside monitor.Coroban said there was a possibility of falling.
An alert icon (red frame) is displayed for patients who have issued an alert.

 Coroban, developed by FRONTEO together with Eisai Co., Ltd., uses AI to analyze nursing records recorded in electronic medical records to assess the risk of falls in hospitalized patients, and identify patients who are at risk of falling from 7 to 2020 days in advance. This is a system that predicts and issues alerts.It was recognized as a recommended product by the Japan Society for Falls Prevention in XNUMX, in recognition of its ability to improve the efficiency and standardization of assessments without increasing the work of medical staff, thereby contributing to improving the quality of care and reducing the workload.

 The smart bed system aggregates information such as sleep/wakefulness, breathing rate, and heart rate of hospitalized patients obtained from sensors and displays it on bedside terminals and staff station terminals, as well as electronic medical record systems, measuring devices, and mobile terminals. This system supports the provision of safe and secure care by collaborating with other organizations to confirm patient information and smoothly share information among medical staff.

 FRONTEO will continue to contribute to the development of drug discovery research and business and the improvement of medical quality through research, development and provision of AI solutions and analysis technology.

 The impact of this matter alone on the Company's business performance will be minor.


■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO is a data analysis company that provides various AI solutions and services using the in-house developed AI engine "KIBIT". Based on the philosophy of "providing solutions that do not overlook risks and opportunities buried in records and realizing fairness in the information society," extract meaningful and important information from vast amounts of text data and complex networks. Our strengths are natural language processing and network analysis technologies that support advanced judgments by experts.We are developing businesses in the areas of legal tech AI, business intelligence, life science AI, and economic security, and contributing to solving various corporate and social issues. Founded in August 2003, listed on Tokyo Stock Exchange Mothers (currently Tokyo Stock Exchange Growth) on June 8, 2007.The company operates in Japan, the United States, South Korea, and Taiwan.Acquisition of first-class medical device manufacturing and sales business license, notification of controlled medical device sales business.Capital 6 thousand yen (as of March 26, 3,042,317).

*Coroban is not a medical device.This system predicts the risk of falls and falls, and is not intended to be used as a judgment by doctors or nurses.
* FRONTEO and KIBIT are registered trademarks of FRONTEO in Japan.
 Coroban is a registered trademark of Eisai & D Management Co., Ltd. and FRONTEO.
 Smart Bed System is a registered trademark of Paramount Bed.

 

<Contact for inquiries from the press>
PR Department, FRONTEO, Inc.
Email: pr_contact@fronteo.com

<Contact for inquiries regarding the life science AI business>
Life Science AI Business Department, FRONTEO, Inc.
https://lifescience.fronteo.com/contact